[1]
M. V. Gusarov, A. N. Barinova, B. M. Tayts, and D. V. Zaslavsky, “Assessment of the cost-effectiveness of stratifying patientswith malignant skin tumors into risk groups: HEALTHCARE ORGANIZATION”, medorg, vol. 11, no. 1, pp. 24–29, July 2026, doi: 10.56871/MHCO.2026.68.23.003.